Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enhance MD vs HealthRX

Enhance MD
Graded #13

Lower grade

vs+1
HealthRX
Graded #9

Higher grade

The verdict

HealthRX takes it — 86/100 to 85/100, but only just.

HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it. Enhance MD is close behind and may still be the better fit — see the factor split below.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthRX +3
82
85
Dose & formulationHealthRX +8
82
90
Clinical oversightEnhance MD +1
88
87
Labs & monitoringEnhance MD +8
90
82
FulfillmentHealthRX +2
84
86
Contract termsHealthRX +1
84
85
Enhance MD · left barHealthRX · right bar

The numbers

MetricEnhance MDHealthRX
WeighScore85/10086/100
GradeBB
Scorecard rank#13#9
Semaglutide$212/mo$189/mo
Tirzepatide$280/mo$349/mo
CoverageNot publicly listedNot publicly listed
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Enhance MD

Graded #13 · B

Strengths

  • Transparent tiered pricing across sema, tirz, microdose, and combo
  • Dose-flat — the price does not step up as you titrate
  • Six-month lab testing plus provider-led care
  • NAD+ longevity adjacency available

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • No oral or sublingual route
  • States served are not published
  • Higher entry price than the cheapest compounded programs
HealthRX

Graded #9 · B

Strengths

  • LegitScript-certified (#50087439) — a genuine, verifiable trust signal
  • Physician-supervised intake with licensed providers
  • Both molecules plus a rare oral GLP tablet option
  • Transparent flat monthly pricing, no insurance required

Where it loses points

  • Compounded semaglutide/tirzepatide is not FDA-approved
  • Some tiers are company-stated and the public site is thin
  • Brand Ozempic is a steep pass-through (~$1,299)
  • State count is not publicly listed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 31 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard